Immune cell subtypes evaluated within the inflammatory infiltrate in the tumor microenvironment focused on T cell subpopulations (CD4+, CD8+), total B cells (CD19+), and NK cells (CD56+) (Figure 1 and Table 3). This evidence concerns the gene CD19 and neoplasm.